Comparison of Endogenous Endophthalmitis in Patients with and Without COVID-19 Infection

Introduction. Endogenous endophthalmitis (EE) is an ophthalmic emergency that can have severe sight-threatening complications. Prompt diagnosis and aggressive treatment are central to the successful management of EE. In recent years, a significant increase has occurred in the number of cases of EE....

Full description

Bibliographic Details
Main Authors: Ehsan Namvar, Mehdi Moallem, Mehrdad Afarid, Alireza Bolkheir
Format: Article
Language:English
Published: Hindawi Limited 2022-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2022/6284569
_version_ 1811186992928522240
author Ehsan Namvar
Mehdi Moallem
Mehrdad Afarid
Alireza Bolkheir
author_facet Ehsan Namvar
Mehdi Moallem
Mehrdad Afarid
Alireza Bolkheir
author_sort Ehsan Namvar
collection DOAJ
description Introduction. Endogenous endophthalmitis (EE) is an ophthalmic emergency that can have severe sight-threatening complications. Prompt diagnosis and aggressive treatment are central to the successful management of EE. In recent years, a significant increase has occurred in the number of cases of EE. Some of these individuals had a COVID-19 infection. The current study compared EE in patients with and without COVID-19 infection. Methods. All cases of EE admitted to Khalili Hospital between April 2020 and September 2021 were included in this prospective case-control study. Patients were divided into 2 groups: (i) the case group (EE patients with confirmed COVID-19 infection; n = 7) and (ii) the control group (EE patients without a history or evidence of COVID-19 infection; n = 7). Age, sex, presenting and final visual acuity, systemic diseases and risk factors for EE, anterior segment and fundus findings, hospitalization due to COVID-19, intensive care unit (ICU) admission, systemic steroid therapy, results of the sepsis workup, causative microorganism, types of treatment (pars plana vitrectomy vs. intravitreal or antifungal antibiotics), and follow-up period were recorded. Results. Twenty-four eyes of the 14 patients were included in this study, of which 9 were female. The mean age was 49.57 years. Follow-ups ranged from 1 month to 20 months (mean, 8 months). There were no statistically significant differences in age (P = 0.653), mean follow-up (P = 0.943), gender (P = 0.313), and clinical presentation (P = 0.409) between the case and control groups. Seven patients (50%) had positive intraocular culture results. Two out of 7 patients had a history of COVID-19 infection. The most common causative microorganism was Candida (4 patients [28.57%]; 6 eyes [25%]). No statistically significant differences were observed between the 2 groups in the need for vitrectomy (P = 1.000). The visual outcome between the 2 groups was similar (P = 0.179). Conclusion. The COVID-19 infection does not seem to affect the severity, visual outcomes, improvement rate, or vitrectomy rate of EE. Early diagnosis and management, especially pars plana vitrectomy, can prevent serious complications and save many eyes.
first_indexed 2024-04-11T13:55:40Z
format Article
id doaj.art-1d67ab15ab0e4be8a13ef91e8fe90f9c
institution Directory Open Access Journal
issn 2090-0058
language English
last_indexed 2024-04-11T13:55:40Z
publishDate 2022-01-01
publisher Hindawi Limited
record_format Article
series Journal of Ophthalmology
spelling doaj.art-1d67ab15ab0e4be8a13ef91e8fe90f9c2022-12-22T04:20:21ZengHindawi LimitedJournal of Ophthalmology2090-00582022-01-01202210.1155/2022/6284569Comparison of Endogenous Endophthalmitis in Patients with and Without COVID-19 InfectionEhsan Namvar0Mehdi Moallem1Mehrdad Afarid2Alireza Bolkheir3Poostchi Ophthalmology Research CenterPoostchi Ophthalmology Research CenterPoostchi Ophthalmology Research CenterPoostchi Ophthalmology Research CenterIntroduction. Endogenous endophthalmitis (EE) is an ophthalmic emergency that can have severe sight-threatening complications. Prompt diagnosis and aggressive treatment are central to the successful management of EE. In recent years, a significant increase has occurred in the number of cases of EE. Some of these individuals had a COVID-19 infection. The current study compared EE in patients with and without COVID-19 infection. Methods. All cases of EE admitted to Khalili Hospital between April 2020 and September 2021 were included in this prospective case-control study. Patients were divided into 2 groups: (i) the case group (EE patients with confirmed COVID-19 infection; n = 7) and (ii) the control group (EE patients without a history or evidence of COVID-19 infection; n = 7). Age, sex, presenting and final visual acuity, systemic diseases and risk factors for EE, anterior segment and fundus findings, hospitalization due to COVID-19, intensive care unit (ICU) admission, systemic steroid therapy, results of the sepsis workup, causative microorganism, types of treatment (pars plana vitrectomy vs. intravitreal or antifungal antibiotics), and follow-up period were recorded. Results. Twenty-four eyes of the 14 patients were included in this study, of which 9 were female. The mean age was 49.57 years. Follow-ups ranged from 1 month to 20 months (mean, 8 months). There were no statistically significant differences in age (P = 0.653), mean follow-up (P = 0.943), gender (P = 0.313), and clinical presentation (P = 0.409) between the case and control groups. Seven patients (50%) had positive intraocular culture results. Two out of 7 patients had a history of COVID-19 infection. The most common causative microorganism was Candida (4 patients [28.57%]; 6 eyes [25%]). No statistically significant differences were observed between the 2 groups in the need for vitrectomy (P = 1.000). The visual outcome between the 2 groups was similar (P = 0.179). Conclusion. The COVID-19 infection does not seem to affect the severity, visual outcomes, improvement rate, or vitrectomy rate of EE. Early diagnosis and management, especially pars plana vitrectomy, can prevent serious complications and save many eyes.http://dx.doi.org/10.1155/2022/6284569
spellingShingle Ehsan Namvar
Mehdi Moallem
Mehrdad Afarid
Alireza Bolkheir
Comparison of Endogenous Endophthalmitis in Patients with and Without COVID-19 Infection
Journal of Ophthalmology
title Comparison of Endogenous Endophthalmitis in Patients with and Without COVID-19 Infection
title_full Comparison of Endogenous Endophthalmitis in Patients with and Without COVID-19 Infection
title_fullStr Comparison of Endogenous Endophthalmitis in Patients with and Without COVID-19 Infection
title_full_unstemmed Comparison of Endogenous Endophthalmitis in Patients with and Without COVID-19 Infection
title_short Comparison of Endogenous Endophthalmitis in Patients with and Without COVID-19 Infection
title_sort comparison of endogenous endophthalmitis in patients with and without covid 19 infection
url http://dx.doi.org/10.1155/2022/6284569
work_keys_str_mv AT ehsannamvar comparisonofendogenousendophthalmitisinpatientswithandwithoutcovid19infection
AT mehdimoallem comparisonofendogenousendophthalmitisinpatientswithandwithoutcovid19infection
AT mehrdadafarid comparisonofendogenousendophthalmitisinpatientswithandwithoutcovid19infection
AT alirezabolkheir comparisonofendogenousendophthalmitisinpatientswithandwithoutcovid19infection